The Wittrup Lab develops protein engineering technology and applies it to the discovery of new biopharmaceuticals. In particular, yeast surface display is used for the directed evolution of protein expression stability, affinity, and specificity.  A particular focus is on the development of anti-cancer drugs, with quantitative studies of cellular-level pharmacokinetics and pharmacodynamics.

Go to the (members only) Wittrup Lab wiki.

NEWS (archives)
Summer 2013: Group alumnus Eric Shusta wins the 2013 ACS BIOT Young Investigator Award. More »

Summer 2013: Adimab LLC executes platform transfer deals with GSK, Biogen Idec. More »

Fall 2012: Group alumnus Jennifer Cochran promoted to Associate Professor of Bioengineering with tenure at Stanford University. More »